Home › Cardiovascular Disease › California › Long Beach
Cardiovascular Disease clinical trials in Long Beach, CA
6 studies for Cardiovascular Disease are looking for participants at sites in and around Long Beach (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
RecruitingPhase 3
- ARK Clinical Research, Long Beach
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
RecruitingPhase 3
- Clinical Trial Site, Long Beach
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
RecruitingPhase 3
- Memorial Care Health System, Long Beach
Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults
RecruitingPhase 4Healthy volunteers welcome
- Long Beach VA Medical Center, Long Beach
Global Paradise System US Post Approval Study
RecruitingObservational study
- Tibor Rubin VA Medical Center, Long Beach
CSP #2026 - Beta Blocker Dialyzability on Cardiovascular Outcomes
RecruitingPhase 3
- VA Long Beach Healthcare System, Long Beach, CA, Long Beach
Cardiovascular Disease trials in other cities
- Boston, MA37 studies
- New York City, NY33 studies
- Washington, DC29 studies
- Houston, TX24 studies
- Dallas, TX23 studies
- Atlanta, GA22 studies
- Cleveland, OH22 studies
- Chicago, IL21 studies
- Philadelphia, PA21 studies
- Pittsburgh, PA20 studies
- St. Louis, MO20 studies
- San Francisco, CA18 studies
Other studies in Long Beach
- Non-Small Cell Lung Cancer12 studies
- Type 2 Diabetes11 studies
- Lung Cancer9 studies
- Breast Cancer9 studies
- Alzheimer's Disease8 studies
- Prostate Cancer7 studies
- Cancer (all types)6 studies
- Obesity5 studies
- Overweight5 studies
- Dementia5 studies
- Steatotic Liver Disease4 studies
- Burkitt Lymphoma4 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.